Veterinary Clinical Studies
We conduct veterinary clinical studies focused on advancing treatments and improving standards of care. Our research is guided by scientific rigor, ethical practices, and real-world clinical insight.
Our Projects
Our goal is to work alongside veterinarians, researchers, and industry partners to advance veterinary clinical studies that lead to meaningful improvements in care. By applying rigorous research standards and ethical practices, we support the development of safe, effective, and innovative solutions that enhance animal health and well-being.
REV-001
REV-001 is an investigational oral chew currently being studied in canines for the management of chronic pain–related conditions. The study focuses on evaluating its safety, effectiveness, and overall tolerance as a potential treatment option for long-term pain management.
The therapy is being developed as an alternative to conventional opioid-based treatments, with the goal of reducing toxicity and minimizing complications commonly associated with prolonged opioid use. Through this research, REV-001 aims to support safer and more sustainable pain management solutions in veterinary care.
REV-002
REV-002 is an oral suspension currently in development for the treatment of canine separation anxiety disorder. This study focuses on assessing the formulation’s safety, effectiveness, and suitability for managing behavioral symptoms associated with anxiety in dogs.
The goal of REV-002 is to provide a reliable therapeutic option that supports emotional well-being and improves quality of life. By exploring non-invasive treatment approaches, this research aims to offer veterinarians and pet owners additional tools for managing separation-related behavioral challenges.
REV-003
REV-003 is an oral suspension under investigation for managing chronic pain in the canines. The research focuses on its safety and effectiveness as a long-term treatment option for dogs experiencing persistent pain.
Designed as a safer alternative to traditional opioid therapies, REV-003 aims to minimize the risk of toxicity and other side effects associated with extended opioid use. This development represents a step toward more effective and responsible pain management in veterinary care.
